These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 436896)

  • 1. Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients.
    Berkelhammer J; Mastrangelo MJ; Bellet RE; Berd D; Prehn RT
    Eur J Cancer (1965); 1979 Feb; 15(2):197-204. PubMed ID: 436896
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
    N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
    [No Abstract]   [Full Text] [Related]  

  • 3. Mumps virus and BCG vaccine in metastatic melanoma.
    Minton JP
    Arch Surg; 1973 Apr; 106(4):503-6. PubMed ID: 4572347
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte function related to survival curves in patients with metastatic melanoma treated by chemoimmunotherapy.
    Thatcher N; Palmer MK; Swindell R; Crowther D
    Med Pediatr Oncol; 1978; 4(1):59-70. PubMed ID: 625264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors.
    Berkelhammer J; Mastrangelo MJ; Laucius JF; Bodurtha AJ; Prehn RT
    Int J Cancer; 1975 Oct; 16(4):571-8. PubMed ID: 51835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
    Knost JA; Reynolds V; Greco FA; Oldham RK
    J Surg Oncol; 1982 Mar; 19(3):165-70. PubMed ID: 7040820
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of a nonrandomized trial in malignant melanoma patients (Clark's stages III--V) treated by post-surgical chemoimmunotherapy.
    Serrou B; Pujol H; Domas J; Gauci L
    Recent Results Cancer Res; 1978; 68():363-6. PubMed ID: 752871
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of malignant melanomas].
    Gallmeier WM
    Haematol Blood Transfus; 1978; 21():293-302. PubMed ID: 367896
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunochemotherapy of human cancer.
    Gutterman JU; Mavligit GM; Reed RC; Hersh EM
    Semin Oncol; 1974 Dec; 1(4):409-23. PubMed ID: 4620443
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunology and cutaneous malignant melanoma.
    Sober AJ
    Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer immunotherapy: an overview.
    Morton DL
    Semin Oncol; 1974 Dec; 1(4):297-310. PubMed ID: 4620437
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.
    Thatcher N; Palmer MK; Gasiunas N; Crowther D
    Br J Cancer; 1977 Dec; 36(6):751-62. PubMed ID: 597473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antitumor reactivity of mononuclear leukocytes from cancer patients receiving immunotherapy with BCG.
    Mavligit GM; Hersh EM
    Med Pediatr Oncol; 1978; 5(1):115-26. PubMed ID: 370532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of administering B.C.G. to patients with melanoma.
    Grant RM; Mackie R; Cochran AJ; Murray EL; Hoyle D; Ross C
    Lancet; 1974 Nov; 2(7889):1096-100. PubMed ID: 4139404
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-Guerin.
    Thatcher N; Blackledge G; Palmer MK; Crowther D
    Eur J Cancer (1965); 1981 Apr; 17(4):465-9. PubMed ID: 7308256
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
    Jacquillat C; Banzet P; Civatte J; Puissant A; Cottenot F; Israel L; Belaich S; Chastang C; Maral J
    Recent Results Cancer Res; 1978; 68():346-58. PubMed ID: 111323
    [No Abstract]   [Full Text] [Related]  

  • 18. A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results.
    Levy NL; Seigler HF; Shingleton WW
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1548-57. PubMed ID: 4421918
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of BCG immunotherapy on alloantigen-induced blastogenesis and cytotoxicity of lymph node lymphocytes in patients with melanoma.
    Callery CD; Morton DL; Golub SH
    Surg Forum; 1979; 30():152-4. PubMed ID: 161421
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
    Einhorn LH; Furnas B
    Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.